Hillenbrand Reports Significantly Lower Preliminary Q1 2026 Revenue and EBITDA
summarizeResumen
The preliminary financial results for the first quarter of fiscal year 2026 indicate a significant weakening in Hillenbrand's operational performance. The projected decline in net revenue and, more critically, the substantial decrease in Adjusted EBITDA (23-34% year-over-year) suggest a challenging quarter. While these results are preliminary and subject to revision, the magnitude of the expected decline is a material negative signal. The disclosure of these figures to prospective investors for the Lone Star Funds acquisition highlights their importance in the ongoing financing and due diligence process, potentially influencing investor perception and the final terms of the deal. Investors should monitor the final Q1 results, expected by February 9, 2026, for confirmation and further details.
check_boxEventos clave
-
Preliminary Q1 2026 Revenue Decline
Net revenue (excluding the divested Milacron business) is estimated to be between $540.0 million and $560.0 million for the three months ended December 31, 2025, down from $596.1 million in the prior year period.
-
Substantial Q1 2026 EBITDA Drop
Consolidated Adjusted EBITDA (excluding Milacron) is projected to be between $57.1 million and $67.1 million for the three months ended December 31, 2025, a significant decrease from $87.3 million in the prior year period.
-
Acquisition Context
These preliminary results were disclosed to prospective investors in connection with the financing for the previously announced proposed acquisition of Hillenbrand by Lone Star Funds.
-
Results are Preliminary
The reported figures are estimates based on internal accounts and are subject to revision as the company completes its financial closing and review procedures, with final results expected by February 9, 2026.
auto_awesomeAnalisis
The preliminary financial results for the first quarter of fiscal year 2026 indicate a significant weakening in Hillenbrand's operational performance. The projected decline in net revenue and, more critically, the substantial decrease in Adjusted EBITDA (23-34% year-over-year) suggest a challenging quarter. While these results are preliminary and subject to revision, the magnitude of the expected decline is a material negative signal. The disclosure of these figures to prospective investors for the Lone Star Funds acquisition highlights their importance in the ongoing financing and due diligence process, potentially influencing investor perception and the final terms of the deal. Investors should monitor the final Q1 results, expected by February 9, 2026, for confirmation and further details.
En el momento de esta presentación, HI cotizaba a 31,82 $ en NYSE dentro del sector Manufacturing, con una capitalización de mercado de aproximadamente 2243,2 M$. El rango de cotización de 52 semanas fue de 18,36 $ a 35,59 $. Este documento fue evaluado con un sentimiento de mercado negativo y una puntuación de importancia de 8 sobre 10.